{"title":"关于神经系统危重病人缺乏药物营养素导致的不良后果的文献综述","authors":"Xiao-Ding Liu, B. Ma","doi":"10.3760/CMA.J.ISSN.1674-635X.2018.01.009","DOIUrl":null,"url":null,"abstract":"Pharmaconutrients refer to macronutrients, micronutrients, microecologics, and nucleotides. Informed by large randomized clinical trials, people have become increasingly prudent in using pharmaconutrients. Critically-ill neurological patients are intensive care patients who have neurological impairment, and therefore command extra caution in using pharmaconutrients. This article reviews the latest studies on the use of pharmaconutrients in this group of patients. \n \n \nKey words: \nCerebrovascular diseases; Pharmaconutrients; Glutamine; Neurological impairment","PeriodicalId":9877,"journal":{"name":"中华临床营养杂志","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2018-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A literature review on adverse outcomes resulting from lack of pharmaconutrients in critically-ill neurological patients\",\"authors\":\"Xiao-Ding Liu, B. Ma\",\"doi\":\"10.3760/CMA.J.ISSN.1674-635X.2018.01.009\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Pharmaconutrients refer to macronutrients, micronutrients, microecologics, and nucleotides. Informed by large randomized clinical trials, people have become increasingly prudent in using pharmaconutrients. Critically-ill neurological patients are intensive care patients who have neurological impairment, and therefore command extra caution in using pharmaconutrients. This article reviews the latest studies on the use of pharmaconutrients in this group of patients. \\n \\n \\nKey words: \\nCerebrovascular diseases; Pharmaconutrients; Glutamine; Neurological impairment\",\"PeriodicalId\":9877,\"journal\":{\"name\":\"中华临床营养杂志\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-02-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"中华临床营养杂志\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3760/CMA.J.ISSN.1674-635X.2018.01.009\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Nursing\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华临床营养杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.1674-635X.2018.01.009","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Nursing","Score":null,"Total":0}
A literature review on adverse outcomes resulting from lack of pharmaconutrients in critically-ill neurological patients
Pharmaconutrients refer to macronutrients, micronutrients, microecologics, and nucleotides. Informed by large randomized clinical trials, people have become increasingly prudent in using pharmaconutrients. Critically-ill neurological patients are intensive care patients who have neurological impairment, and therefore command extra caution in using pharmaconutrients. This article reviews the latest studies on the use of pharmaconutrients in this group of patients.
Key words:
Cerebrovascular diseases; Pharmaconutrients; Glutamine; Neurological impairment